Circular RNA circEIF3C promotes intrahepatic cholangiocarcinoma progression and immune evasion via the miR-34a-5p/B7-H4 axis
- PMID: 37223528
- PMCID: PMC10201671
- DOI: 10.1016/j.gendis.2022.05.005
Circular RNA circEIF3C promotes intrahepatic cholangiocarcinoma progression and immune evasion via the miR-34a-5p/B7-H4 axis
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
NFIX Circular RNA Promotes Glioma Progression by Regulating miR-34a-5p via Notch Signaling Pathway.Front Mol Neurosci. 2018 Jul 18;11:225. doi: 10.3389/fnmol.2018.00225. eCollection 2018. Front Mol Neurosci. 2018. PMID: 30072869 Free PMC article.
-
MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer.Transl Oncol. 2023 May;31:101653. doi: 10.1016/j.tranon.2023.101653. Epub 2023 Mar 11. Transl Oncol. 2023. PMID: 36907052 Free PMC article.
-
The miR-34a/WNT7B modulates the sensitivity of cholangiocarcinoma cells to p53-mediated photodynamic therapy toxicity.Biochem Biophys Res Commun. 2022 Feb 5;591:54-61. doi: 10.1016/j.bbrc.2021.12.070. Epub 2021 Dec 21. Biochem Biophys Res Commun. 2022. PMID: 34999254
-
Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.Cell Death Dis. 2017 Dec 13;8(12):3205. doi: 10.1038/s41419-017-0015-6. Cell Death Dis. 2017. PMID: 29235470 Free PMC article.
-
Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription.J Hepatol. 2022 Jan;76(1):135-147. doi: 10.1016/j.jhep.2021.08.027. Epub 2021 Sep 9. J Hepatol. 2022. PMID: 34509526
Cited by
-
Upregulation of long noncoding RNAs LINC00941 and ABHD11-AS1 is associated with intrahepatic cholangiocarcinoma.Sci Prog. 2025 Jan-Mar;108(1):368504251330019. doi: 10.1177/00368504251330019. Epub 2025 Mar 28. Sci Prog. 2025. PMID: 40151866 Free PMC article.
-
Circular RNAs: key players in tumor immune evasion.Mol Cell Biochem. 2025 Jun;480(6):3267-3295. doi: 10.1007/s11010-024-05186-8. Epub 2025 Jan 4. Mol Cell Biochem. 2025. PMID: 39754640 Review.
-
ZNF460-mediated upregulation of APCDD1L-DT promotes cholangiocarcinoma development by inhibiting the ubiquitin-mediated degradation of DVL2.Cancer Gene Ther. 2024 Oct;31(10):1585-1597. doi: 10.1038/s41417-024-00826-z. Epub 2024 Aug 30. Cancer Gene Ther. 2024. PMID: 39210030
-
Biological functions of circRNA in regulating the hallmarks of gastrointestinal cancer (Review).Int J Oncol. 2024 May;64(5):49. doi: 10.3892/ijo.2024.5637. Epub 2024 Mar 15. Int J Oncol. 2024. PMID: 38488023 Free PMC article. Review.
-
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications.Cancers (Basel). 2024 Oct 20;16(20):3542. doi: 10.3390/cancers16203542. Cancers (Basel). 2024. PMID: 39456636 Free PMC article. Review.
References
-
- Kristensen L.S., Andersen M.S., Stagsted L.V.W., Ebbesen K.K., Hansen T.B., Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. - PubMed
-
- Iizuka A., Nonomura C., Ashizawa T., et al. A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv antibody targets human breast cancer. Clin Cancer Res. 2019;25(9):2925–2934. - PubMed
-
- Lu Y., Wu F., Cao Q., et al. B7-H4 is increased in lung adenocarcinoma harboring EGFR-activating mutations and contributes to immunosuppression. Oncogene. 2022;41(5):704–717. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials